ClinicalTrials.gov
public full text
Public Domain
Brain GABA Levels and Treatment Response in Major Depressive Disorder
This study will evaluate changes in brain gamma-aminobutyric acid (GABA) levels due to treatment with escitalopram in people with major depressive disorder.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Pattern Separation in Major Depressive Disorder#1045410
- Cipralex in Treatment of Depressive Symptoms and Chronic Back Pain#1088214
- Ketamine Associated ACC GABA and Glutamate Change and Depression Remission:#849667
- Aβ Dynamics in LLMD#853911
- The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients#839929
Record · ID 830825
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive